Limitations, agreements, and source contact

Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma · Source last updated 2023-10-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

mrosenzweig@coh.org

organization

Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA 91010

phone

626-218-2405

title

Michael Rosenzweig, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice